Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News


en.sedaily.com > society > 09/14/2026 > busan-to-cover-80-percent-of-delivery-riders-injury

Busan to Cover 80% of Delivery Riders' Injury Insurance Premiums

20+ hour, 16+ min ago   (341+ words) Up to 200,000 Won for About 4,000 Workers City Aims to Ease Burden Amid High Fuel and Living Costs BUSAN — The Busan city government will cover 80% of the industrial accident insurance premiums that platform workers such as delivery riders and substitute drivers…...


en.sedaily.com > finance > 09/10/2026 > celltrions-omlyclo-now-sold-in-26-european-countries

Celltrion's Omlyclo Now Sold in 26 European Countries

4+ day, 6+ hour ago   (182+ words) Seoul Economic Daily Celltrion (068270) is expanding sales of Omlyclo, its biosimilar version of omalizumab, which is now marketed in 26 European countries Omlyclo is used to treat chronic spontaneous urticaria and allergic asthma Omalizumab is an antibody therapy that works by…...


en.sedaily.com > society > 09/08/2026 > uijeongbu-meets-west-virginia-delegation-to-back-insulin

Uijeongbu Meets West Virginia Delegation to Back Insulin Firm's U.S. Push

6+ day, 6+ hour ago   (297+ words) West Virginia Government and Academic Officials Attend Talks Focus on Investment Ties With Locally Based Unt Bio City Pledges Administrative Support for Insulin Material Commercialization UIJEONGBU — The city of Uijeongbu in Gyeonggi Province met with a West Virginia delegation at…...


en.sedaily.com > finance > 09/07/2026 > dong-a-st-takes-wearable-monitoring-device-to-six-asia

Dong-A ST Takes Wearable Monitoring Device to Six Asia-Pacific Markets

1+ week, 13+ hour ago   (263+ words) Supply Deal Signed With Schiller Asia Pacific Distribution to Run Through Local Networks in Thailand, Australia and Elsewhere More Than 800 Hospitals in Korea Already Use the Device Dong-A ST is stepping up its push into the Asia-Pacific digital healthcare market…...


en.sedaily.com > technology > 09/07/2026 > daewoong-pharmaceutical-accelerates-global-push-for-nabota

Daewoong Pharmaceutical Accelerates Global Push for Nabota Toxin

1+ week, 14+ hour ago   (305+ words) Partners From 22 Countries Gather on Jeju for Three-Day Program Nabota Edge Event Shares Marketing Strategies With 40 Staff Product Approved in 69 Countries, Partnerships in About 80 Nabota, the botulinum toxin from Daewoong Pharmaceutical (069620.KS) that has surpassed 1 trillion won ($720 million) in cumulative…...


en.sedaily.com > finance > 09/05/2026 > korean-firms-turn-to-obesity-drugs-pet-leave-to-keep-staff

Korean Firms Turn to Obesity Drugs, Pet Leave to Keep Staff

1+ week, 2+ day ago   (367+ words) Employee benefits have become as important as pay in South Korea's job market, and companies are rolling out increasingly unconventional perks to attract and retain talent. Pearl Abyss (263750) offers one of the most striking examples. The game developer recently launched…...


en.sedaily.com > finance > 09/02/2026 > prestige-biopharma-executives-step-up-share-purchases

Prestige Biopharma Executives Step Up Share Purchases

1+ week, 5+ day ago   (347+ words) IDC Chief Executive Ko Sang-seok Buys on Open Market Move Signals Confidence in Biosimilar Commercialization, R&D Prestige Biopharma (950210) executives have been buying company shares one after another, signaling confidence in the company's biosimilar commercialization drive and its research and…...


en.sedaily.com > technology > 09/01/2026 > korea-adds-rare-epilepsy-drug-to-insurance-cutting-annual

Korea Adds Rare Epilepsy Drug to Insurance, Cutting Annual Cost to 10 Million Won

1+ week, 6+ day ago   (316+ words) Dravet Syndrome Treatment Cost Falls From About 100 Million Won a Year Blood Cancer Drugs Polivy and Blincyto Also Gain or Expand Coverage Annual treatment costs for patients with Dravet syndrome, a rare and intractable form of epilepsy, will fall to…...


en.sedaily.com > finance > 09/01/2026 > cuckoo-homesys-cuts-mattress-rental-fees-by-up-to-53-percent

Cuckoo Homesys Cuts Mattress Rental Fees by Up to 53%

1+ week, 6+ day ago   (172+ words) Company Runs Restino Bedroom Promotion Sales Volume Jumped 207% Last Year Home appliance maker Cuckoo Homesys (284740.KQ) said on the 1st that it will run a "Restino Bedroom Promotion" offering discounts of up to 53% on rental fees for mattresses and bed frames....